Congratulations to the newest CSL Global Research Acceleration Initiative partnership awardees. Seven medical researchers have been awarded a CSL Research Acceleration Initiative \(RAI\) partnership, including up to a AU$500,000 investment in each program over two years, to fast-track the discovery of innovative biotherapies to address unmet medical needs. The CSL Research Acceleration Initiative establishes partnerships between CSL and global research organisations to accelerate commercialisation of promising discovery programs. In addition to creating long-term mutual partnerships to further innovation, the initiative includes funding as well as access to CSL R&D experts. To learn more about the investigators and technologies selected in the 2022 program, click here https://bit.ly/46BNLzc
Seven New CSL Global Research Acceleration Initiative Awardees Announced to Fast-Track Therapeutics Innovation
Initiative Freshly Inks Promising Research Partnerships in Europe and, for the first time, Asia and the UK
Vita: Original Stories
'Vita' means life. It's also where we share the stories of biotech's promise to patients and public health.
Video: Getting to Know CSL Vifor
Watch a video that introduces CSL Vifor’s role as the “home of iron” at its manufacturing site in St. Gallen, Switzerland.
CSL's Chief Sustainability Officer on Climate Week 2023
Expanding deep collaboration across industries will help make meaningful advancement on our shared goals.
New Book on Emil von Behring
Just in time for Nobel Prize week, a historian in Marburg, Germany, has authored a biography of von Behring.
Careers at CSL
We are committed to helping employees fulfill their career aspirations while working in a values-based culture. Are you next?